Prostate Cancer - Results from #25360

Focal therapy, differential therapy, and radiation treatment for prostate cancer - Abstract July 26, 2012

Analysis of survival in radical and postoperative radiotherapy for prostate cancer - Abstract July 26, 2012

Docetaxel-induced fatal interstitial pneumonitis in a patient with castration-resistant prostate cancer - Abstract July 26, 2012

High-grade prostatic intraepithelial neoplasia - Abstract July 26, 2012

Focal laser ablation of prostate cancer: Definition, needs, and future - Abstract July 26, 2012

Quality-of-life outcomes in high-risk prostate cancer patients treated with helical tomotherapy in a hypofractionated radiation schedule with long-term androgen suppression - Abstract July 26, 2012

Obesity and prostate cancer : Role of adipocytokines and clinical implications - Abstract July 26, 2012

Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study - Abstract July 26, 2012

Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI - Abstract July 25, 2012

Prostate cancer - A biomarker perspective - Abstract July 25, 2012

Toward maximizing immunotherapy in metastatic castration-resistant prostate cancer - Rationale for combinatorial approaches using chemotherapy - Abstract July 25, 2012

Applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients - Abstract July 25, 2012

Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate - Abstract July 25, 2012

Prostate cancer screening: Attitudes and practices of family physicians in Ontario - Abstract July 25, 2012

Prostate Cancer Localization using Multiparametric MRI based on Semi-supervised Techniques with Automated Seed Initialization - Abstract July 25, 2012

Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate - Abstract July 25, 2012

Successful treatment of advanced metastatic prostate cancer following chemotherapy based on molecular profiling - Abstract July 25, 2012

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy - Abstract July 24, 2012

Prostate-specific membrane antigen-based imaging - Abstract July 24, 2012

Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue - Abstract July 24, 2012

Page 1269 of 1437